Gemifloxacin (LB20304; SB265805; Factive) is a 3rd generation, orally bioavailable, and broad-spectrum quinolone antibacterial agent approved for use in the treatment of acute bacterial exacerbation of chronic bronchitis, and mild-to-moderate pneumonia.

纯度：≥98%

CAS：175463-14-6